Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vitamin D Deficiency 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycystic Ovary Syndrome 2Neoplasms 1Multiple Sclerosis, Relapsing-Remitting 1Giant Cell Tumor of Bone 1Gastrointestinal Neoplasms 1Cognitive Dysfunction 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1Cachexia 1

Interventions

Sorafenib 46lenvatinib 44apatinib 23sintilimab 22Fluorouracil 21camrelizumab 20Oxaliplatin 17Radiofrequency Ablation 16Radiosurgery 15Hepatectomy 15tislelizumab 14Leucovorin 14Radiotherapy 12Doxorubicin 12toripalimab 11Folfox protocol 10Bevacizumab 10Immune Checkpoint Inhibitors 9Epirubicin 9regorafenib 8Ethiodized Oil 8durvalumab 7donafenib 7anlotinib 7Neoadjuvant Therapy 7pembrolizumab 6entecavir 6Surgical Procedures, Operative 6Nivolumab 6Injections 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Hepatocellular × Vitamin D × Clear all
NCT05650151 2022-12-14

Peri-operative Vitamin D Therapy for Hepatectomy

National Taiwan University Hospital

Phase NA Unknown
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Vitamin D Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡